Back to Search Start Over

Previous Exacerbations Predict the Risk of Future Exacerbations After Stopping Versus Continuing Mepolizumab Treatment: Secondary Analysis of the COMET Trial

Authors :
Mark C. Liu
E. Mavropoulou
N. Kaneko
Wendy C. Moore
R.G. Price
O. Kornmann
Stephen G. J. Smith
Steven W. Yancey
Neil Martin
Marc Humbert
Martyn J. Gilson
Elisabeth H. Bel
Source :
TP10. TP010 CLINICAL AND POPULATION-LEVEL STUDIES OF ASTHMA.
Publication Year :
2021
Publisher :
American Thoracic Society, 2021.

Subjects

Subjects :
medicine.medical_specialty
business.industry
Secondary analysis
Internal medicine
Comet
medicine
business
Mepolizumab
medicine.drug

Details

Database :
OpenAIRE
Journal :
TP10. TP010 CLINICAL AND POPULATION-LEVEL STUDIES OF ASTHMA
Accession number :
edsair.doi...........c54860570edb99843cb66da1770d71c7
Full Text :
https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1445
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details